(Q35615151)

9 August 2017

1 reference

title

Adjunctive dexamethasone treatment in acute bacterial meningitis (English)

1 reference

9 August 2017

1 reference

1 reference

Abhijit Chaudhuri

1

1 reference

9 August 2017

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

3

1 reference

9 August 2017

1

1 reference

9 August 2017

54-62

1 reference

Infectious Diseases: Considerations for the 21st Century

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Fifteen years of experience with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Twelve year outcomes following bacterial meningitis: further evidence for persisting effects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Bacterial meningitis in the United States in 1995. Active Surveillance Team

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Acute bacterial meningitis in children admitted to the Queen Elizabeth Central Hospital, Blantyre, Malawi in 1996-97.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Trends in antimicrobial resistance of Streptococcus pneumoniae in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Survival and sequelae of meningococcal meningitis in Ghana.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Serogroup B, electrophoretic type 15 Neisseria meningitidis in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Pneumococcal meningitis in adults: Spectrum of complications and prognostic factors in a series of 87 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Current status of cortisol findings in post-traumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Relation of Concentrations of Bacteria and Bacterial Antigen in Cerebrospinal Fluid to Prognosis in Patients with Bacterial Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Bacterial meningitis: pathogenesis, pathophysiology, and progress

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Reprogramming the host response in bacterial meningitis: how best to improve outcome?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Cytokines and chemokines in meningeal inflammation: biology and clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Why pus is bad for the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Expression of death-related proteins in dentate granule cells in human bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Neuroprotection by a caspase inhibitor in acute bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Bilateral hippocampal volume loss in patients with a history of encephalitis or meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Dexamethasone adjunctive therapy for bacterial meningitis in children: a retrospective study in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Dexamethasone treatment for bacterial meningitis in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Dexamethasone in adults with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Dexamethasone and bacterial meningitis in Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Rich nations, poor nations, and bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Diagnosis and treatment of bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Klebsiella meningitis in adults: clinical features, prognostic factors and therapeutic outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Corticosteroids for everyone with meningitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Evaluation of vancomycin for therapy of adult pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Neuronal injury in bacterial meningitis: mechanisms and implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Early treatment with parenteral penicillin in meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Meningococcal infections: reducing the case fatality rate by giving penicillin before admission to hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Early parenteral penicillin in meningococcal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Early treatment of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Diagnosis and treatment of viral encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

α4Integrins as Therapeutic Targets in Autoimmune Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900623-9

7 January 2021

10.1016/S1474-4422(03)00623-9

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14693112